184 related articles for article (PubMed ID: 27999147)
1. Quantitative profiling of endocannabinoids and related
Kantae V; Ogino S; Noga M; Harms AC; van Dongen RM; Onderwater GL; van den Maagdenberg AM; Terwindt GM; van der Stelt M; Ferrari MD; Hankemeier T
J Lipid Res; 2017 Mar; 58(3):615-624. PubMed ID: 27999147
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms.
Morgan CJ; Page E; Schaefer C; Chatten K; Manocha A; Gulati S; Curran HV; Brandner B; Leweke FM
Br J Psychiatry; 2013 May; 202(5):381-2. PubMed ID: 23580381
[TBL] [Abstract][Full Text] [Related]
3. Leptin levels are negatively correlated with 2-arachidonoylglycerol in the cerebrospinal fluid of patients with osteoarthritis.
Nicholson J; Azim S; Rebecchi MJ; Galbavy W; Feng T; Reinsel R; Rizwan S; Fowler CJ; Benveniste H; Kaczocha M
PLoS One; 2015; 10(4):e0123132. PubMed ID: 25835291
[TBL] [Abstract][Full Text] [Related]
4. Determination of endocannabinoids and N-acylethanolamines in human hair with LC-MS/MS and their relation to symptoms of depression, burnout, and anxiety.
Gao W; Walther A; Wekenborg M; Penz M; Kirschbaum C
Talanta; 2020 Sep; 217():121006. PubMed ID: 32498885
[TBL] [Abstract][Full Text] [Related]
5. Determination of anandamide in cerebrospinal fluid samples by disposable pipette extraction and ultra-high performance liquid chromatography tandem mass spectrometry.
Oliveira IGC; Marchioni C; Queiroz MEC
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Nov; 1130-1131():121809. PubMed ID: 31669634
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids in chronic migraine: CSF findings suggest a system failure.
Sarchielli P; Pini LA; Coppola F; Rossi C; Baldi A; Mancini ML; Calabresi P
Neuropsychopharmacology; 2007 Jun; 32(6):1384-90. PubMed ID: 17119542
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and
Couttas TA; Boost C; Pahlisch F; Sykorova EB; Leweke JE; Koethe D; Endepols H; Rohleder C; Leweke FM
Cannabis Cannabinoid Res; 2023 Aug; 8(4):657-669. PubMed ID: 35580134
[No Abstract] [Full Text] [Related]
8. Alterations of endocannabinoids in cerebrospinal fluid of dogs with epileptic seizure disorder.
Gesell FK; Zoerner AA; Brauer C; Engeli S; Tsikas D; Tipold A
BMC Vet Res; 2013 Dec; 9():262. PubMed ID: 24370333
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis.
Di Filippo M; Pini LA; Pelliccioli GP; Calabresi P; Sarchielli P
J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1224-9. PubMed ID: 18535023
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy.
Romigi A; Bari M; Placidi F; Marciani MG; Malaponti M; Torelli F; Izzi F; Prosperetti C; Zannino S; Corte F; Chiaramonte C; Maccarrone M
Epilepsia; 2010 May; 51(5):768-72. PubMed ID: 19817812
[TBL] [Abstract][Full Text] [Related]
11. Pitfalls in the sample preparation and analysis of N-acylethanolamines.
Skonberg C; Artmann A; Cornett C; Hansen SH; Hansen HS
J Lipid Res; 2010 Oct; 51(10):3062-73. PubMed ID: 20447930
[TBL] [Abstract][Full Text] [Related]
12. Analysis of endocannabinoids in plasma samples by biocompatible solid-phase microextraction devices coupled to mass spectrometry.
Acquaro Junior VR; Goméz-Ríos GA; Tascon M; Costa Queiroz ME; Pawliszyn J
Anal Chim Acta; 2019 Dec; 1091():135-145. PubMed ID: 31679567
[TBL] [Abstract][Full Text] [Related]
13. Quantification of endocannabinoids in human cerebrospinal fluid using a novel micro-flow liquid chromatography-mass spectrometry method.
He B; Di X; Guled F; Harder AVE; van den Maagdenberg AMJM; Terwindt GM; Krekels EHJ; Kohler I; Harms A; Ramautar R; Hankemeier T
Anal Chim Acta; 2022 Jun; 1210():339888. PubMed ID: 35595362
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry.
Lam PM; Marczylo TH; Konje JC
Anal Bioanal Chem; 2010 Nov; 398(5):2089-97. PubMed ID: 20835819
[TBL] [Abstract][Full Text] [Related]
15. A quantitiative LC-MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma.
Gachet MS; Rhyn P; Bosch OG; Quednow BB; Gertsch J
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 976-977():6-18. PubMed ID: 25436483
[TBL] [Abstract][Full Text] [Related]
16. Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.
Leweke FM; Giuffrida A; Koethe D; Schreiber D; Nolden BM; Kranaster L; Neatby MA; Schneider M; Gerth CW; Hellmich M; Klosterkötter J; Piomelli D
Schizophr Res; 2007 Aug; 94(1-3):29-36. PubMed ID: 17566707
[TBL] [Abstract][Full Text] [Related]
17. Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS.
Fanelli F; Di Lallo VD; Belluomo I; De Iasio R; Baccini M; Casadio E; Gasparini DI; Colavita M; Gambineri A; Grossi G; Vicennati V; Pasquali R; Pagotto U
J Lipid Res; 2012 Mar; 53(3):481-493. PubMed ID: 22172516
[TBL] [Abstract][Full Text] [Related]
18. Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry.
Richardson D; Ortori CA; Chapman V; Kendall DA; Barrett DA
Anal Biochem; 2007 Jan; 360(2):216-26. PubMed ID: 17141174
[TBL] [Abstract][Full Text] [Related]
19. UHPLC-ESI-MS/MS assay for quantification of endocannabinoids in cerebrospinal fluid using surrogate calibrant and surrogate matrix approaches.
Aydin E; Cebo M; Mielnik J; Richter H; Schüle R; Sievers-Engler A; Młynarz P; Lämmerhofer M
J Pharm Biomed Anal; 2023 Jan; 222():115090. PubMed ID: 36252552
[TBL] [Abstract][Full Text] [Related]
20. Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol.
Rubio M; McHugh D; Fernández-Ruiz J; Bradshaw H; Walker JM
Neurosci Lett; 2007 Jun; 421(3):270-4. PubMed ID: 17574742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
